Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).

Cells · 2023 · PMC10741398 · PMID 38132093

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, it is important to note that these changes did not reach statistical significance.

also in 111,027 other papers

a positive trendno p-value reported

While this study may be underpowered to reliably detect significant efficacy, it is worth noting that a positive trend in treatment effectiveness was observed with the MoCA scores, although it did not reach conventional statistical significance ( p = 0.099).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.